Haematological malignancies presenting with acute liver injury: a single-centre experience

被引:1
|
作者
Shetty, S. [1 ]
Holt, A. P. [2 ]
Syn, W. -K. [3 ]
Fox, C. P. [4 ]
Gunson, B. [1 ]
Neil, D. [5 ]
Haydon, G. [1 ]
机构
[1] Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England
[2] Univ Hosp Coventry & Warwickshire, Dept Gastroenterol, Coventry, W Midlands, England
[3] Duke Univ, Dept Gastroenterol, Durham, NC USA
[4] Queen Elizabeth Hosp, Dept Haematol, Birmingham B15 2TH, W Midlands, England
[5] Queen Elizabeth Hosp, Dept Pathol, Birmingham B15 2TH, W Midlands, England
关键词
D O I
10.1093/qjmed/hcn121
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Early recognition and identification of the underlying cause of acute liver injury (ALI) is crucial in instituting medical treatment and assessing the need for liver transplantation. Haematological malignancies have been reported to present as ALI with progression to acute liver failure but experience is limited. Aim: Review our experience of ALI secondary to haematological malignancies. Patients and methods: Patients admitted to the liver unit with ALI secondary to a haematological malignancy between 1996 and 2006 were identified. A retrospective review was made of their case notes and our database. Results: Of the 752 cases of ALI, six cases of ALI secondary to haematological malignancy were identified. Common features were a prodromal illness (median duration of 5 weeks; range 26 weeks) and jaundice (median bilirubin 208 mol/l; range 112238 mol/l). The majority of patients (5/6) had hepatomegaly. Liver biopsy was performed in two patients and confirmed the diagnosis in both cases. In other cases, the diagnosis was made following lymph node biopsy (1), bone marrow examination (2) or from post-mortem examination (1). Median time from jaundice to encephalopathy was 12 days; range 122 days. A single patient underwent liver transplantation but died in the immediate post-operative period. All patients died soon after admission with a median survival of 8 days (range 326 days). Conclusion: Haematological malignancy should be considered in ALI patients presenting with a prodromal illness, jaundice and hepatomegaly. Biopsy is essential to confirm the diagnosis but the benefit of definitive therapy such as chemotherapy and/or transplantation in this setting is unclear and survival is poor.
引用
收藏
页码:949 / 953
页数:5
相关论文
共 50 条
  • [1] Haematological malignancies presenting with acute liver failure: A single centre experience
    Shetty, S.
    Holt, A.
    Syn, W.
    Gunson, B.
    Haydon, G.
    [J]. GUT, 2007, 56 : A133 - A133
  • [2] Palonosetron (Aloxi): a single-centre experience in the prevention of emesis in patients affected by haematological malignancies
    Basile, D.
    Assanelli, A.
    Soliman, C.
    Ciceri, F.
    Matozzo, V.
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 : S361 - S361
  • [3] Haplo-identical SCT as a salvage therapy in haematological malignancies: a single-centre experience
    Paina, O.
    Stankevich, Y.
    Kazantsev, I.
    Stancheva, N.
    Golovacheva, A.
    Babenko, E.
    Alyanskiy, A.
    Ivanova, N.
    Semenova, E.
    Krugliakov, P.
    Polyntzev, D.
    Zoubarovskaya, L.
    Afanasyev, B.
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 : S380 - S380
  • [4] A Single-Centre Experience of Obstetric Acute Kidney Injury
    Mishra Vineet V.
    Goyal Preeti A.
    Aggarwal Rohina S.
    Choudhary S.
    Tanvir T.
    Dharaiya Nisarg D.
    Gaddagi Rashmi A.
    [J]. The Journal of Obstetrics and Gynecology of India, 2016, 66 (Suppl 1) : 207 - 211
  • [5] RISK FACTORS FOR ACUTE KIDNEY INJURY AFTER LIVER TRANSPLANTATION: SINGLE-CENTRE EXPERIENCE
    Franusic, Lucija
    Pavicic-Saric, Jadranka
    Jurekovic, Zeljka
    Kosuta, Iva
    Mikulic, Danko
    Kocman, Branislav
    Bekan, Ivan-Budimir
    Knotek, Mladen
    Mrzljak, Anna
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 237 - 237
  • [6] Haematopoietic stem cell transplantation for haematological malignancies: a 5-year single-centre experience
    Georgievski, B
    Cevreska, L
    Siljanovski, N
    Stojanovic, A
    Karanfilski, O
    Stojanoski, Z
    Stavrik, SG
    Panovska, I
    Balkanov, SK
    Pivkova, A
    [J]. BONE MARROW TRANSPLANTATION, 2006, 37 : S332 - S332
  • [7] Fludarabine in lymphoproliferative malignancies: A single-centre experience
    Prabhash, K.
    Vikram, G. S.
    Nair, R.
    Sengar, M.
    Gujral, S.
    Bakshi, A.
    Gupta, S.
    Parikh, P. M.
    [J]. NATIONAL MEDICAL JOURNAL OF INDIA, 2008, 21 (04): : 171 - 174
  • [8] Acute-on-chronic liver failure: a single-centre experience
    Skladany, L'ubomir
    Jancekova, Daniela
    Vnencakova, Janka
    Selcanova, Svetlana Adamcova
    Bystrianska, Natalia
    Svac, Juraj
    [J]. CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 6 (02) : 92 - 98
  • [9] Liver retransplantation: a single-centre experience
    Ma Yi
    Wang Guo-Dong
    He Xiao-Shun
    Li Jun-Liang
    [J]. CHINESE MEDICAL JOURNAL, 2008, 121 (20) : 1987 - 1991
  • [10] Long-term survival after stem cell transplantation for haematological malignancies: single-centre experience
    Georgievski, B.
    Pivkova, A.
    Stojanoski, Z.
    Stavrik, S. Genadieva
    Balkanov, S. Krstevska
    Cevreska, L.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S399 - S400